RS49837B - Upotreba 8a-azalida u veterini kao antimikrobna sredstva - Google Patents

Upotreba 8a-azalida u veterini kao antimikrobna sredstva

Info

Publication number
RS49837B
RS49837B YUP-147/00A YU14700A RS49837B RS 49837 B RS49837 B RS 49837B YU 14700 A YU14700 A YU 14700A RS 49837 B RS49837 B RS 49837B
Authority
RS
Serbia
Prior art keywords
azalides
antimicrobial agents
spp
veterinary antimicrobial
veterinary
Prior art date
Application number
YUP-147/00A
Other languages
English (en)
Inventor
Helmut Kropp
Daniel O. FARRINGTON
Jeffrey N. CLARK
Ronald W. RATCLIFFE
Robert D. WILKENING
Original Assignee
Merck&Co.Inc.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck&Co.Inc., filed Critical Merck&Co.Inc.,
Publication of YU14700A publication Critical patent/YU14700A/sh
Publication of RS49837B publication Critical patent/RS49837B/sr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Primena 8a-azalida, naznačena time što se koristi za proizvodnju leka za lečenje ili prevenciju bakterijske respiratome infekcije kod goveda i svinja izazvane sa Pasteurella spp., Actircobacillus spp., Haemophilus somnus ili Mycoplasma spp.
YUP-147/00A 1997-09-10 1998-09-04 Upotreba 8a-azalida u veterini kao antimikrobna sredstva RS49837B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5832997P 1997-09-10 1997-09-10
GBGB9806029.6A GB9806029D0 (en) 1998-03-20 1998-03-20 8a-Azalides as veterinary antimicrobial agents

Publications (2)

Publication Number Publication Date
YU14700A YU14700A (sh) 2002-11-15
RS49837B true RS49837B (sr) 2008-08-07

Family

ID=10828979

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-147/00A RS49837B (sr) 1997-09-10 1998-09-04 Upotreba 8a-azalida u veterini kao antimikrobna sredstva

Country Status (22)

Country Link
EP (2) EP1510214B1 (sr)
CN (1) CN1152681C (sr)
AT (2) ATE283055T1 (sr)
AU (1) AU730172B2 (sr)
BR (1) BR9812066A (sr)
CA (1) CA2301872C (sr)
CZ (1) CZ289868B6 (sr)
DE (1) DE69827814T2 (sr)
DK (2) DK1011664T3 (sr)
EA (1) EA001530B1 (sr)
ES (2) ES2376432T3 (sr)
GB (1) GB9806029D0 (sr)
HU (1) HU228758B1 (sr)
IL (1) IL134762A (sr)
ME (1) ME00858B (sr)
NZ (1) NZ503145A (sr)
PL (1) PL192915B1 (sr)
PT (2) PT1510214E (sr)
RS (1) RS49837B (sr)
SI (2) SI1011664T1 (sr)
SK (1) SK284791B6 (sr)
WO (1) WO1999012542A1 (sr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6353096B1 (en) 1999-04-01 2002-03-05 Merial Process of use in converting the 4″(S)-OH functional group of the cladinose unit of an azamacrolide to 4″(R)-NH2
FR2788524B1 (fr) * 1999-01-18 2002-04-26 Merial Sas Procede utile pour transformer la fonction 4"(s)-oh du motif cladinose d'un aza macrolide en 4"(r)-nh2
GB0025688D0 (en) 2000-10-19 2000-12-06 Glaxo Group Ltd Macrolides
US7799937B2 (en) 2004-10-25 2010-09-21 Synthonics, Inc. Metal coordinated compositions
US20060141054A1 (en) 2004-10-25 2006-06-29 Thomas Piccariello Metal coordinated compositions
US8779175B2 (en) 2004-10-25 2014-07-15 Synthonics, Inc. Coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients
EP1879904A1 (en) * 2005-05-10 2008-01-23 GlaxoSmithKline istrazivacki centar Zagreb d.o.o. 4" amino linked macrolides useful for the treatment of microbial infections

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5281518A (en) * 1986-05-01 1994-01-25 Washington Research Foundation Detection of a unique chlamydia strain associated with acute respiratory disease
GB8726384D0 (en) * 1987-11-11 1987-12-16 Coopers Animal Health Veterinary treatment
US4956294A (en) * 1988-03-07 1990-09-11 Merck & Co., Inc. Culture of Streptoverticillium synroense for producing an antibacterial
CA2064634C (en) * 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
US5202434A (en) * 1991-04-05 1993-04-13 Merck & Co., Inc. 8a-aza-8a-homoerythromycin lactams
US5189159A (en) * 1992-04-02 1993-02-23 Merck & Co., Inc. 8a-AZA-8a-homoerythromycin cyclic iminoethers
EP0549040A1 (en) * 1991-12-20 1993-06-30 Merck & Co. Inc. Methods of making 4" derivatives of 9-deoxo-8a-aza-8a-alkyl-8a-homoerythromycin A

Also Published As

Publication number Publication date
EP1011664B1 (en) 2004-11-24
HU228758B1 (en) 2013-05-28
CN1152681C (zh) 2004-06-09
BR9812066A (pt) 2000-09-26
PT1011664E (pt) 2005-02-28
CN1278722A (zh) 2001-01-03
ATE535248T1 (de) 2011-12-15
AU730172B2 (en) 2001-03-01
CA2301872C (en) 2006-12-19
PL339140A1 (en) 2000-12-04
NZ503145A (en) 2001-02-23
EP1510214A2 (en) 2005-03-02
CA2301872A1 (en) 1999-03-18
SI1011664T1 (en) 2005-02-28
CZ2000896A3 (cs) 2000-10-11
IL134762A0 (en) 2001-04-30
SI1510214T1 (sl) 2012-04-30
IL134762A (en) 2005-08-31
ES2376432T3 (es) 2012-03-13
WO1999012542A1 (en) 1999-03-18
SK3222000A3 (en) 2001-01-18
DE69827814D1 (de) 2004-12-30
EA001530B1 (ru) 2001-04-23
PT1510214E (pt) 2012-02-06
ATE283055T1 (de) 2004-12-15
DK1510214T3 (da) 2012-03-19
YU14700A (sh) 2002-11-15
ES2232964T3 (es) 2005-06-01
DE69827814T2 (de) 2005-11-24
EA200000305A1 (ru) 2000-08-28
EP1011664A4 (en) 2001-05-16
AU9566498A (en) 1999-03-29
ME00858B (me) 2008-08-07
PL192915B1 (pl) 2006-12-29
EP1510214B1 (en) 2011-11-30
DK1011664T3 (da) 2005-02-14
HUP0003845A3 (en) 2003-05-28
CZ289868B6 (cs) 2002-04-17
HUP0003845A2 (hu) 2001-08-28
GB9806029D0 (en) 1998-05-20
EP1510214A3 (en) 2005-03-23
SK284791B6 (sk) 2005-11-03
EP1011664A1 (en) 2000-06-28

Similar Documents

Publication Publication Date Title
KR930700492A (ko) 혈당 저하제로서의 3-아릴-2-하이드록시프로피온산 유도체 및 그의 유사체
NO971192L (no) Fremgangsmåter for avlevering av materialer inn i huden, og sammensetninger som blir anvendt
BR0112750A (pt) Aminopiperidina quinolinas e seus análogos azaisostéricos com atividade antibacteriana
BE2011C037I2 (sr)
BR9609176A (pt) Composi-{es de agente biolÄgico
PE20001112A1 (es) Derivados de quinolina como agentes antibacterianos
PT806941E (pt) Composicoes anti-bacterianas liposomicas de rigidez baixa
ES2184800T3 (es) Uso de agentes anti-vegf en el tratamiento de la endometriosis.
MY131300A (en) Antibacterial agents
EP1037650A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF STAPHYLOCOCCUS AUREUS INFECTIONS
NO953995D0 (no) Ionenolymere som anthelmintica i dyr
BR0308710A (pt) conjugados poliméricos antimicrobianos
RS49837B (sr) Upotreba 8a-azalida u veterini kao antimikrobna sredstva
NZ510153A (en) Tan-1057 derivatives with reduced toxicity and their use in medicaments for treating bacterial infections in humans and mammals
YU39598A (sh) Upotreba duloksetina i njegova farmaceutska smeša
WO1999012552A8 (en) 9a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS
PT1052991E (pt) Utilizacao de loperamida para o tratamento de infeccoes microbianas
BR0308734A (pt) Composto, composição farmacêutica, uso do composto, e, método para prevenir ou tratar infecção
EA200101171A1 (ru) Способ лечения инфекций, вызванных streptococcus pneumoniae
BR0214494A (pt) Fatores antibióticos ge 81112 a, b, b1, seus sais e composições farmaceuticamente aceitáveis e uso dos mesmos
ZA901320B (en) Compositions for the treatment of microbial infections
ES2076107A1 (es) Derivados de antibioticos macrolidos de anillos de 16 miembros.
BR9800686A (pt) Agente coccidicida e bactericida para aves e suìnos.